By using the unique panel of isogenic and non-isogenic breast cancer cell lines with the distinct p53 deficiencies, we identified functional outcomes of p53LOH in mutp53 heterozygous cells that may underlie the selective pressure for p53LOH. This evidence concerns the gene TP53 and breast carcinoma.